Procalcitonin, brain natriuretic peptide and albumin as markers to predict prognosis in hospitalized older Japanese patients with a risk of infection

Toshihiro Higashikawa,Toru Ito,Tomohiko Ito,Takuro Mizuno,Keiichirou Ishigami,Kengo Kuroki,Naoto Maekawa,Daisuke Usuda,Michiteru Yoshida,Takuro Morita,Kazu Hamada,Hiroshi Yano,Kento Takeshima,Takatoshi Haraguchi,Shinya Yamada,Sohsuke Yamada,Tomoyuki Ushimoto,Ryusho Sangen,Toshihide Izumida,Jun Kiyosawa,Taisuke Ono,Masaharu Iguchi,Yukihiro Wato,Takeshi Nakahashi,Yuji Kasamaki,Akihiro Fukuda,Tsugiyasu Kanda,Shigeto Morimoto,Masashi Okuro

DOI: https://doi.org/10.1111/ggi.14887

2024-05-03

Geriatrics and Gerontology International

Abstract:These figures show Kaplan–Meier plots indicating cumulative survival rate according to four levels of procalcitonin concentration (<0.5, 0.5–2, 2–10 and ≥10 ng/mL), two levels of brain natriuretic peptide concentration (<300 and ≥300 pg/mL) and two levels of albumin concentration (<2.5 and ≥2.5 g/dL). The survival rate was decreased as the serum procalcitonin concentration increased from <0.5 to ≥10 ng/mL, as was also the case with brain natriuretic peptide concentration from <300 to ≥300 pg/mL, whereas low albumin (<2.5 g/dL) showed a lower survival rate than high albumin (≥2.5 g/dL; P

geriatrics & gerontology,gerontology